Literature DB >> 19234177

Engagement of CD83 on B cells modulates B cell function in vivo.

Birte Kretschmer1, Katja Lüthje, Stefanie Schneider, Bernhard Fleischer, Minka Breloer.   

Abstract

The transmembrane glycoprotein CD83 is an important regulator of both thymic T cell maturation and peripheral T cell response. Recent studies suggested that CD83 is also involved in the regulation of B cell maturation, activation, and homeostasis. In this study, we show that in vivo overexpression of CD83 dose dependently interfered with the Ig response to thymus-dependent and thymus-independent model Ag immunization. CD83 deficiency, in contrast, which was restricted to B cells in mixed bone marrow chimeras, led to unchanged or even slightly increased Ig responses. Strikingly, the engagement of CD83 that is naturally up-regulated on wild-type B cells by injection of anti-CD83 mAb in vivo induced a 100-fold increase in the IgG1 response to immunization. Kinetic analysis revealed that CD83 had to be engaged simultaneously or shortly after the B cell activation through injection of Ag, to modulate the IgG1 secretion. Furthermore, using mixed bone marrow chimeras in which either selectively the B cells or the dendritic cells were CD83 deficient, we demonstrate that anti-CD83 mAb mediated its biologic effect by engaging CD83 on B cells and not on CD11c(+) dendritic cells. Taken together, we provide strong evidence that CD83 transduces regulatory signals into the very B cell on which it is expressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234177     DOI: 10.4049/jimmunol.0803153

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer.

Authors:  Fuqiang Dai; Lunxu Liu; Guowei Che; Nanbin Yu; Qiang Pu; Shangfu Zhang; Junliang Ma; Lin Ma; Zongbing You
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

2.  Targeting CD83 for the treatment of graft-versus-host disease.

Authors:  Xiongfei Wang; Ming Q Wei; Xiaosong Liu
Journal:  Exp Ther Med       Date:  2013-04-02       Impact factor: 2.447

Review 3.  CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.

Authors:  Ziduo Li; Xinsheng Ju; Pablo A Silveira; Edward Abadir; Wei-Hsun Hsu; Derek N J Hart; Georgina J Clark
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

Review 4.  The CD83 Molecule - An Important Immune Checkpoint.

Authors:  Linda Grosche; Ilka Knippertz; Christina König; Dmytro Royzman; Andreas B Wild; Elisabeth Zinser; Heinrich Sticht; Yves A Muller; Alexander Steinkasserer; Matthias Lechmann
Journal:  Front Immunol       Date:  2020-04-17       Impact factor: 7.561

5.  Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy.

Authors:  Honghui Zeng; Le Wang; Jiajia Li; Siweier Luo; Qianqian Han; Fang Su; Jing Wei; Xiaona Wei; Jianping Wu; Bin Li; Jingang Huang; Patrick Tang; Chunwei Cao; Yiming Zhou; Qiongqiong Yang
Journal:  Cell Biosci       Date:  2021-12-11       Impact factor: 7.133

6.  CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infection.

Authors:  Sariah J Allen; Kevin R Mott; Aziz A Chentoufi; Lbachir BenMohamed; Steven L Wechsler; Christie M Ballantyne; Homayon Ghiasi
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

7.  Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis.

Authors:  J M Bates; K Flanagan; L Mo; N Ota; J Ding; S Ho; S Liu; M Roose-Girma; S Warming; L Diehl
Journal:  Mucosal Immunol       Date:  2014-09-10       Impact factor: 7.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.